Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Bacterial Peritonitis | Research

A risk score to predict 30-day hospital readmission rate in cirrhotic patients with spontaneous bacterial peritonitis

Authors: Nasser Mousa, Ahmed Abdel-Razik, Sherif Elbaz, Mohamed Salah, Mohammed Abdelaziz, Alaa Habib, Ahmed Deib, Abdel-Naser Gadallah, Niveen El-wakeel, Waleed Eldars, Narmin effat, Ola El-Emam, Khaled Taha, Alaa Elmetwalli, Eman Mousa, Dina Elhammady

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background and aim

There is lack of 30-day hospital readmission prediction score in patients with liver cirrhosis and SBP. The aim of this study is to recognize factors capable of predicting 30-day readmission and to develop a readmission risk score in patients with SBP.

Methods

This study prospectively examined the 30-day hospital readmission for patients previously discharged with a diagnosis of SBP. Based on index hospitalization variables, a multivariable logistic regression model was implemented to recognize predictors of patient hospital readmission within 30 days. Consequently, Mousa readmission risk score was established to predict 30-day hospital readmission.

Results

Of 475 patients hospitalized with SBP, 400 patients were included in this study. The 30-day readmission rate was 26.5%, with 16.03% of patients readmitted with SBP. Age ≥ 60, MELD > 15, serum bilirubin > 1.5 mg/dL, creatinine > 1.2 mg/dL, INR > 1.4, albumin < 2.5 g/dL, platelets count ≤ 74 (103/dL) were found to be independent predictors of 30-day readmission. Incorporating these predictors, Mousa readmission score was established to predict 30-day patient readmissions. ROC curve analysis demonstrated that at a cutoff value ≥ 4, Mousa score had optimum discriminative power for predicting the readmission in SBP with sensitivity 90.6% and specificity 92.9%. However, at cutoff value ≥ 6 the sensitivity and specificity were 77.4% and 99.7%, respectively, while a cutoff value ≥ 2 had sensitivity of 99.1% and specificity of 31.6%.

Conclusions

The 30-day readmission rate of SBP was 25.6%. With the suggested simple risk assessment Mousa score, patients at high risk for early readmission can be easily identified so as to possibly prevent poorer outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28:e10–8.CrossRefPubMed Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28:e10–8.CrossRefPubMed
2.
go back to reference Ripoll C, Groszmann R, Garcia-Tsao G, Burroughs A, Planas R, Escorsell A, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.CrossRefPubMed Ripoll C, Groszmann R, Garcia-Tsao G, Burroughs A, Planas R, Escorsell A, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.CrossRefPubMed
3.
go back to reference Elmoghazy M, El Shabrawi A, Mousa N. Portal Hypertension, an Overview. Med J Viral Hepatitis. 2019;4(1):15–21. Elmoghazy M, El Shabrawi A, Mousa N. Portal Hypertension, an Overview. Med J Viral Hepatitis. 2019;4(1):15–21.
4.
go back to reference Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.CrossRefPubMed Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.CrossRefPubMed
5.
go back to reference Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28(3):e10-18.CrossRefPubMed Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28(3):e10-18.CrossRefPubMed
6.
go back to reference Ibrahim I, Elbadrawy E, Nasr D. Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital. Med J Viral Hepatitis. 2020;4(2):75–80.CrossRef Ibrahim I, Elbadrawy E, Nasr D. Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital. Med J Viral Hepatitis. 2020;4(2):75–80.CrossRef
7.
go back to reference Karvellas CJ, Abraldes JG, Arabi YM, Kumar A. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther. 2015;41(8):747–57.CrossRefPubMed Karvellas CJ, Abraldes JG, Arabi YM, Kumar A. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther. 2015;41(8):747–57.CrossRefPubMed
8.
go back to reference European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417.CrossRef European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417.CrossRef
9.
go back to reference Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: the clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304–14.CrossRefPubMedPubMedCentral Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: the clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304–14.CrossRefPubMedPubMedCentral
10.
go back to reference Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–37.CrossRefPubMed Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–37.CrossRefPubMed
11.
go back to reference Cheong HS, Kang CI, Lee JA, Moon SY, Joung MK, Chung DR, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009;48:1230–6.CrossRefPubMed Cheong HS, Kang CI, Lee JA, Moon SY, Joung MK, Chung DR, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009;48:1230–6.CrossRefPubMed
12.
go back to reference Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42.CrossRefPubMed Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42.CrossRefPubMed
13.
go back to reference Ghassemi H, Garcia-Tsao G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:77–93.CrossRefPubMed Ghassemi H, Garcia-Tsao G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:77–93.CrossRefPubMed
14.
go back to reference de Mattos AA, Costabeber AM, Lionço LC, Tovo CV. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management? World J Gastroenterol. 2014;20:14079–86.CrossRefPubMedPubMedCentral de Mattos AA, Costabeber AM, Lionço LC, Tovo CV. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management? World J Gastroenterol. 2014;20:14079–86.CrossRefPubMedPubMedCentral
15.
go back to reference Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol. 2019;18(1):30–9.CrossRefPubMed Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol. 2019;18(1):30–9.CrossRefPubMed
16.
go back to reference Morales BPP. Early hospital readmission in decompensated cir-rhosis: incidence, impact on mortality, and predictive factors. Dig Liver Dis. 2017;49:903–9.CrossRefPubMed Morales BPP. Early hospital readmission in decompensated cir-rhosis: incidence, impact on mortality, and predictive factors. Dig Liver Dis. 2017;49:903–9.CrossRefPubMed
17.
go back to reference Berman KT. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.[Erratum appears in Clin Gastroenterol Hepatol. 2011 Jul; 9 (7):625 Note: vuppalanch, Raj [corrected to Vuppalanchi, Raj]. Clin Gastroenterol Hepatol. 2011;9:254–259.. Berman KT. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.[Erratum appears in Clin Gastroenterol Hepatol. 2011 Jul; 9 (7):625 Note: vuppalanch, Raj [corrected to Vuppalanchi, Raj]. Clin Gastroenterol Hepatol. 2011;9:254–259..
18.
go back to reference Singal AGR. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11(1335–1341): e1. Singal AGR. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11(1335–1341): e1.
19.
go back to reference Bajaj JSR. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200–8.CrossRefPubMed Bajaj JSR. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200–8.CrossRefPubMed
20.
go back to reference Volk ML, Tocco RS, Bazick J, et al. Hospital re -admissions among patients with decompensated cirrhosis. Am J Gastroen-terol. 2012;107:247–52.CrossRef Volk ML, Tocco RS, Bazick J, et al. Hospital re -admissions among patients with decompensated cirrhosis. Am J Gastroen-terol. 2012;107:247–52.CrossRef
21.
go back to reference Tapper EBF. Standard assessments of frailty are validated predic-tors of mortality in hospitalized patients with cirrhosis. Hepatol-ogy. 2015;62:584–90.CrossRef Tapper EBF. Standard assessments of frailty are validated predic-tors of mortality in hospitalized patients with cirrhosis. Hepatol-ogy. 2015;62:584–90.CrossRef
22.
go back to reference Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, Matheny ME. Predicting 30-day hospital readmission risk in a national cohort of patients with cirrhosis. Dig Dis Sci. 2020;65(4):1003–31.CrossRefPubMed Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, Matheny ME. Predicting 30-day hospital readmission risk in a national cohort of patients with cirrhosis. Dig Dis Sci. 2020;65(4):1003–31.CrossRefPubMed
23.
go back to reference Orman ES, Ghabril M, Emmett TW, et al. Hospital readmis-sions in patients with cirrhosis: a systematic review. J Hosp Med. 2018;13(7):490–5.CrossRefPubMed Orman ES, Ghabril M, Emmett TW, et al. Hospital readmis-sions in patients with cirrhosis: a systematic review. J Hosp Med. 2018;13(7):490–5.CrossRefPubMed
24.
go back to reference Dahiya DS, Sanaka MR, Kichloo A, Singh A, Wachala J, Perisetti A, et al. Early readmissions of spontaneous bacterial peritonitis in the USA: Insights into an emerging challenge. J Gastroenterol Hepatol. 2022;89:6. Dahiya DS, Sanaka MR, Kichloo A, Singh A, Wachala J, Perisetti A, et al. Early readmissions of spontaneous bacterial peritonitis in the USA: Insights into an emerging challenge. J Gastroenterol Hepatol. 2022;89:6.
25.
go back to reference EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69: 406–460. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69: 406–460.
26.
go back to reference Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordran’s gastrointestinal and liver disease. 8th ed. Saunders: Philadelphia; 2006. p. 1935–64. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordran’s gastrointestinal and liver disease. 8th ed. Saunders: Philadelphia; 2006. p. 1935–64.
27.
go back to reference Nasser M, Sahar Z, Mohamed AM. The predictive factors for recurrence of spontaneous bacterial peritonitis. Med J Viral Hepatitis. 2018;2(2):25–9. Nasser M, Sahar Z, Mohamed AM. The predictive factors for recurrence of spontaneous bacterial peritonitis. Med J Viral Hepatitis. 2018;2(2):25–9.
29.
go back to reference El-Shabrawi A, Mohammed Abdelaziz A, Mousa N. Infections in cirrhotic patients. Med J Viral Hepatitis. 2019;4(1):5–14. El-Shabrawi A, Mohammed Abdelaziz A, Mousa N. Infections in cirrhotic patients. Med J Viral Hepatitis. 2019;4(1):5–14.
30.
go back to reference Elbatae H, Ahmed Abdel-Razik A, Mousa E. Periodontal disease as predictor of chronic liver diseases. Med J Viral Hepatitis. 2020;4(2):57–61. Elbatae H, Ahmed Abdel-Razik A, Mousa E. Periodontal disease as predictor of chronic liver diseases. Med J Viral Hepatitis. 2020;4(2):57–61.
32.
go back to reference Hines AL, Marguerite LB, Joanna J, Claudia AS. "Conditions with the largest number of adult hospital readmissions by payer, 2011: statistical brief# 172." 2014. Hines AL, Marguerite LB, Joanna J, Claudia AS. "Conditions with the largest number of adult hospital readmissions by payer, 2011: statistical brief# 172." 2014.
33.
go back to reference Marciano S, Díaz JM, Dirchwolf M, Gadano A. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med. 2019;11:13–22.CrossRefPubMedPubMedCentral Marciano S, Díaz JM, Dirchwolf M, Gadano A. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med. 2019;11:13–22.CrossRefPubMedPubMedCentral
34.
go back to reference Abdel-Razik A, Abdelsalam M, Gad DF, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors. Eur J Gastroenterol Hepatol. 2020;32(6):718–26.CrossRefPubMed Abdel-Razik A, Abdelsalam M, Gad DF, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors. Eur J Gastroenterol Hepatol. 2020;32(6):718–26.CrossRefPubMed
35.
go back to reference Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases. Hepatology. 2021;74(2):1014–48. https://doi.org/10.1002/hep.31884.CrossRefPubMed Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases. Hepatology. 2021;74(2):1014–48. https://​doi.​org/​10.​1002/​hep.​31884.CrossRefPubMed
36.
go back to reference Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Dig Dis. 2016;34(4):382–6.CrossRefPubMed Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Dig Dis. 2016;34(4):382–6.CrossRefPubMed
37.
go back to reference Termsinsuk P, Auesomwang C. Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients. Int J Clin Pract. 2020;74(3): e13457.CrossRefPubMed Termsinsuk P, Auesomwang C. Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients. Int J Clin Pract. 2020;74(3): e13457.CrossRefPubMed
38.
go back to reference Marciano S, Dirchwolf M, Diaz JM, et al. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin. Eur J Gastroenterol Hepatol. 2019;31(4):540–6.CrossRefPubMed Marciano S, Dirchwolf M, Diaz JM, et al. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin. Eur J Gastroenterol Hepatol. 2019;31(4):540–6.CrossRefPubMed
39.
go back to reference Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331–41.CrossRefPubMed Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331–41.CrossRefPubMed
40.
go back to reference Chirapongsathorn S, Krittanawong C, Enders FT, Pendegraft R, Mara KC, Borah BJ, Visscher SL, Loftus CG, Shah VH, Talwalkar JA, Kamath PS. Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis. Hepatol Commun. 2018;2(2):188–98.CrossRefPubMedPubMedCentral Chirapongsathorn S, Krittanawong C, Enders FT, Pendegraft R, Mara KC, Borah BJ, Visscher SL, Loftus CG, Shah VH, Talwalkar JA, Kamath PS. Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis. Hepatol Commun. 2018;2(2):188–98.CrossRefPubMedPubMedCentral
41.
go back to reference Bedreli S, Sowa JP, Gerken G, Saner FH, Canbay A. Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis. Gut. 2016;65:357–8.CrossRefPubMed Bedreli S, Sowa JP, Gerken G, Saner FH, Canbay A. Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis. Gut. 2016;65:357–8.CrossRefPubMed
42.
go back to reference Koola JD, Ho S, Chen G, Perkins AM, Cao A, Davis SE, Matheny ME. Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis. BMJ Open Gastroenterol. 2019;6(1): e000342.CrossRefPubMedPubMedCentral Koola JD, Ho S, Chen G, Perkins AM, Cao A, Davis SE, Matheny ME. Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis. BMJ Open Gastroenterol. 2019;6(1): e000342.CrossRefPubMedPubMedCentral
43.
go back to reference Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne). 2021;31(8): 646875.CrossRef Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne). 2021;31(8): 646875.CrossRef
Metadata
Title
A risk score to predict 30-day hospital readmission rate in cirrhotic patients with spontaneous bacterial peritonitis
Authors
Nasser Mousa
Ahmed Abdel-Razik
Sherif Elbaz
Mohamed Salah
Mohammed Abdelaziz
Alaa Habib
Ahmed Deib
Abdel-Naser Gadallah
Niveen El-wakeel
Waleed Eldars
Narmin effat
Ola El-Emam
Khaled Taha
Alaa Elmetwalli
Eman Mousa
Dina Elhammady
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01126-2

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue